Skip to Content

Tag: Graham Goodrich

Also Noted

Apnimed makes critical additions to C-suite 

January 22, 2024HME News Staff

CAMBRIDGE, Mass. – Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacological therapies for the treatment of obstructive sleep apnea and related disorders, has named Graham Goodrich as chief commercial officer and Ted Harding as chief human resources officer. The company says the additions to the C-suite are critical as the company prepares to launch AD109, a potential nighttime oral treatment currently in Phase 3. “We are thrilled to have attracted two...

Apnimed, Graham Goodrich, Obstructive Sleep Apnea (OSA), oral therapy, Ted Harding

Read Full Articlered right arrow icon